We are live on ! Find out more
AGN

Allergan Inc
AGN

Delisted

AGN was delisted on the 16th of March, 2015.

Back to rankings

23 hedge funds and large institutions have $22.3M invested in Allergan Inc in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

18% less funds holding

Funds holding: 28 → 23 (-5)

42% less capital invested

Capital invested by funds: $38.4M → $22.3M (-$16.1M)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
23
Holders Change
-5
Holders Change %
-17.86%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
7
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SGCM
Sand Grove Capital Management
United Kingdom
+$9.16M
2
CK
Carnick & Kubik
Colorado
+$1.32M
3
MAM
Mark Asset Management
New York
+$268K
4
GIM
Grassi Investment Management
California
+$134K
5
AWM
Altavista Wealth Management
North Carolina
+$76.1K

Top Sellers

Rank Fund Capital Flow
1
SL
Summitry LLC
California
-$20.4M
2
III
Independent Investors Inc
New York
-$1.72M
3
DAM
Doheny Asset Management
California
-$230K
4
TFA
Toth Financial Advisory
Virginia
-$223K
5
RCM
Reynolds Capital Management
Nevada
-$219K
Name Holding Trade Value Shares
Change 		Change in
Stake
SGCM
1
Sand Grove Capital Management
United Kingdom
$9.16M +$9.16M +33,400 New
AWM
2
Altavista Wealth Management
North Carolina
$3.18M +$76.1K +284 +2%
CK
3
Carnick & Kubik
Colorado
$1.32M +$1.32M +4,918 New
MMPW
4
Mitchell McLeod Pugh & Williams
Alabama
$1.06M – – –
ODCM
5
Old Dominion Capital Management
Virginia
$969K -$34.3K -128 -3%
DY
6
Dowling & Yahnke
California
$764K +$72.7K +271 +11%
GIM
7
Grassi Investment Management
California
$713K +$134K +500 +23%
HHAA
8
Henry H. Armstrong Associates
Pennsylvania
$694K +$24.1K +90 +4%
AGA
9
Accuvest Global Advisors
Utah
$584K – – –
LCM
10
Liberty Capital Management
Michigan
$571K -$12.3K -46 -2%
AAC
11
Asset Advisors Corp
Georgia
$536K -$9.66K -36 -2%
MAM
12
Mark Asset Management
New York
$536K +$268K +1,000 +100%
SIA
13
Starfire Investment Advisers
Michigan
$495K – – –
GJIC
14
Gamble Jones Investment Counsel
California
$348K -$69.9K -261 -17%
FWCM
15
Ferguson Wellman Capital Management
Oregon
$344K – – –
PAA
16
Peregrine Asset Advisers
Oregon
$302K -$134K -500 -31%
CIS
17
Connors Investor Services
Pennsylvania
$268K – – –
MA
18
Marshwinds Advisory
Georgia
$248K – – –
BC
19
Bartlett & Co
Ohio
$124K – – –
GAM
20
Gemmer Asset Management
California
$42K +$9.1K +34 +28%
NCM
21
Nelson Capital Management
California
$38K +$38K +142 New
ARMC
22
American Research & Management Company
Massachusetts
$9K – – –
LP
23
LMR Partners
United Kingdom
$4.5K +$3.17K +11,835 +239%
SL
24
Summitry LLC
California
– -$20.4M -65,189 Closed
III
25
Independent Investors Inc
New York
– -$1.72M -5,500 Closed
1
2

AGN Hedge Fund Activity: Q1 2016 in Review

23 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q1 2016, worth a combined $22.3M — down 42% from $38.4M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of AGN and 3 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 7 added.

The largest buyer was Sand Grove Capital Management, opening a new position worth an estimated $9.16M. The largest seller was Summitry LLC, exiting entirely with an estimated $20.4M sold.

  • 23 institutional investors held Allergan Inc (AGN) as of Q1 2016, down from 28 in Q4 2015.
  • Funds reported $22.3M of Allergan Inc stock for Q1 2016, down 42% quarter-over-quarter.
  • 3 funds opened new Allergan Inc positions in Q1 2016 and 7 closed out, a net change of -4 holders.
  • The largest Allergan Inc buyer in Q1 2016 was Sand Grove Capital Management, an estimated $9.16M added.
  • The largest Allergan Inc seller in Q1 2016 was Summitry LLC, an estimated $20.4M sold.

Based on aggregated 13F filings for Q1 2016.